Cargando…

Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?

The pathogenesis of delayed cerebral edema after intracerebral hemorrhage is still unclear. In this case report, we speculate that the formation of subdural effusion or hemorrhage is associated with delayed cerebral edema. By referring to the treatment plan of chronic subdural hematoma, adding dexam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yongqing, Xu, Jin, Han, Yuhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395021/
https://www.ncbi.nlm.nih.gov/pubmed/37539239
http://dx.doi.org/10.1016/j.heliyon.2023.e17621
_version_ 1785083501010223104
author Ye, Yongqing
Xu, Jin
Han, Yuhan
author_facet Ye, Yongqing
Xu, Jin
Han, Yuhan
author_sort Ye, Yongqing
collection PubMed
description The pathogenesis of delayed cerebral edema after intracerebral hemorrhage is still unclear. In this case report, we speculate that the formation of subdural effusion or hemorrhage is associated with delayed cerebral edema. By referring to the treatment plan of chronic subdural hematoma, adding dexamethasone to routine medication, certain therapeutic effect has been achieved. Dexamethasone may maintain the stability of blood-brain barrier by directly increasing the expression of ZO-1, and reduce the neuroinflammatory response caused by NF-κB pathway by upregulating KLF2 expression, ultimately reducing nerve injury through multiple pathways.
format Online
Article
Text
id pubmed-10395021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103950212023-08-03 Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be? Ye, Yongqing Xu, Jin Han, Yuhan Heliyon Case Report The pathogenesis of delayed cerebral edema after intracerebral hemorrhage is still unclear. In this case report, we speculate that the formation of subdural effusion or hemorrhage is associated with delayed cerebral edema. By referring to the treatment plan of chronic subdural hematoma, adding dexamethasone to routine medication, certain therapeutic effect has been achieved. Dexamethasone may maintain the stability of blood-brain barrier by directly increasing the expression of ZO-1, and reduce the neuroinflammatory response caused by NF-κB pathway by upregulating KLF2 expression, ultimately reducing nerve injury through multiple pathways. Elsevier 2023-06-28 /pmc/articles/PMC10395021/ /pubmed/37539239 http://dx.doi.org/10.1016/j.heliyon.2023.e17621 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ye, Yongqing
Xu, Jin
Han, Yuhan
Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title_full Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title_fullStr Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title_full_unstemmed Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title_short Dexamethasone for delayed edema after intracerebral hemorrhage: To be or not to be?
title_sort dexamethasone for delayed edema after intracerebral hemorrhage: to be or not to be?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395021/
https://www.ncbi.nlm.nih.gov/pubmed/37539239
http://dx.doi.org/10.1016/j.heliyon.2023.e17621
work_keys_str_mv AT yeyongqing dexamethasonefordelayededemaafterintracerebralhemorrhagetobeornottobe
AT xujin dexamethasonefordelayededemaafterintracerebralhemorrhagetobeornottobe
AT hanyuhan dexamethasonefordelayededemaafterintracerebralhemorrhagetobeornottobe